Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study
Introduction Patients with poor perioperative glycaemic control after total joint arthroplasty are at an increased risk of complications, mortality, delayed return to function and increased costs of care. Although correction of hyperglycaemia has been shown to improve patient outcomes, there is a la...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/4/e091446.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849763512240308224 |
|---|---|
| author | Aidan Morrell Steven Shelofsky Hannah Hoffman Cole McCallister Thomas W Huff Kathryn L Schabel Avital Y O’Glasser Ryland P Kagan |
| author_facet | Aidan Morrell Steven Shelofsky Hannah Hoffman Cole McCallister Thomas W Huff Kathryn L Schabel Avital Y O’Glasser Ryland P Kagan |
| author_sort | Aidan Morrell |
| collection | DOAJ |
| description | Introduction Patients with poor perioperative glycaemic control after total joint arthroplasty are at an increased risk of complications, mortality, delayed return to function and increased costs of care. Although correction of hyperglycaemia has been shown to improve patient outcomes, there is a lack of consensus regarding optimal perioperative glucose management after total joint replacement surgery. This pilot study aims to assess the feasibility of performing a multicentre randomised controlled trial to investigate the effect of perioperative metformin use on glycaemic control in the setting of total joint arthroplasty.Methods and analysis This blinded, placebo-controlled, pilot randomised controlled trial will enrol 40 participants aged 18–99 years undergoing total hip or knee arthroplasty at a single academic tertiary centre. Patients will be randomly allocated to two groups of 20 participants each and will receive metformin or a placebo, respectively, for 2 weeks preoperatively, continued on the day of surgery, and up to 2 days postoperatively. The primary outcome is a composite of four endpoints to assess study feasibility: timely recruitment, timely study drug administration, protocol adherence and retention. Secondary outcomes include perioperative glycaemic variability, sliding scale insulin utilisation, hospital length of stay and 90-day rates of infection, mortality and readmission. Analyses will be on an intention-to-treat basis.Ethics and dissemination The protocol was approved by Oregon Health & Science University Institutional Review Board, STUDY00025798. Written informed consent will be obtained for study participation. Findings will be disseminated via publication in peer-reviewed journals and conference presentations.Trial registration number NCT06280274. |
| format | Article |
| id | doaj-art-c2b11228da02444cb4ac679f6407940c |
| institution | DOAJ |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-c2b11228da02444cb4ac679f6407940c2025-08-20T03:05:24ZengBMJ Publishing GroupBMJ Open2044-60552025-04-0115410.1136/bmjopen-2024-091446Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot studyAidan Morrell0Steven Shelofsky1Hannah Hoffman2Cole McCallister3Thomas W Huff4Kathryn L Schabel5Avital Y O’Glasser6Ryland P Kagan7Orthopaedics, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAHospital Medicine, Oregon Health & Science University, Portland, Oregon, USAOrthopaedics, Oregon Health & Science University, Portland, Oregon, USAIntroduction Patients with poor perioperative glycaemic control after total joint arthroplasty are at an increased risk of complications, mortality, delayed return to function and increased costs of care. Although correction of hyperglycaemia has been shown to improve patient outcomes, there is a lack of consensus regarding optimal perioperative glucose management after total joint replacement surgery. This pilot study aims to assess the feasibility of performing a multicentre randomised controlled trial to investigate the effect of perioperative metformin use on glycaemic control in the setting of total joint arthroplasty.Methods and analysis This blinded, placebo-controlled, pilot randomised controlled trial will enrol 40 participants aged 18–99 years undergoing total hip or knee arthroplasty at a single academic tertiary centre. Patients will be randomly allocated to two groups of 20 participants each and will receive metformin or a placebo, respectively, for 2 weeks preoperatively, continued on the day of surgery, and up to 2 days postoperatively. The primary outcome is a composite of four endpoints to assess study feasibility: timely recruitment, timely study drug administration, protocol adherence and retention. Secondary outcomes include perioperative glycaemic variability, sliding scale insulin utilisation, hospital length of stay and 90-day rates of infection, mortality and readmission. Analyses will be on an intention-to-treat basis.Ethics and dissemination The protocol was approved by Oregon Health & Science University Institutional Review Board, STUDY00025798. Written informed consent will be obtained for study participation. Findings will be disseminated via publication in peer-reviewed journals and conference presentations.Trial registration number NCT06280274.https://bmjopen.bmj.com/content/15/4/e091446.full |
| spellingShingle | Aidan Morrell Steven Shelofsky Hannah Hoffman Cole McCallister Thomas W Huff Kathryn L Schabel Avital Y O’Glasser Ryland P Kagan Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study BMJ Open |
| title | Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study |
| title_full | Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study |
| title_fullStr | Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study |
| title_full_unstemmed | Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study |
| title_short | Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study |
| title_sort | perioperative metformin use in patients undergoing total joint replacement surgery protocol for a randomised placebo controlled pilot study |
| url | https://bmjopen.bmj.com/content/15/4/e091446.full |
| work_keys_str_mv | AT aidanmorrell perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT stevenshelofsky perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT hannahhoffman perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT colemccallister perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT thomaswhuff perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT kathrynlschabel perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT avitalyoglasser perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy AT rylandpkagan perioperativemetforminuseinpatientsundergoingtotaljointreplacementsurgeryprotocolforarandomisedplacebocontrolledpilotstudy |